Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease

VANCOUVER BRITISH COLUMBIA Marketwired 030317 Qu Biologics Inc. a biopharmaceutical company developing Site Specific Immunomodulators SSIs that aim to "reboot" the body's innate immune system reports positive genetic analyses of their recentl...